Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?
Authors:
- 21 April 2017
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 19 (6) , 47
Abstract
Omega-3 fatty acids are increasingly used for the protection of cardiovascular disease. The main but not the sole mechanism of action is the reduction of triglyceride levels. In this review, we summarize the effect of omega-3 supplements on all-cause and cardiovascular mortality, myocardial infarction, and stroke from the relevant randomized controlled trials.Keywords
This publication has 45 references indexed in Scilit:
- A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease RiskMayo Clinic Proceedings, 2017
- 2016 ESC/EAS Guidelines for the Management of DyslipidaemiasEuropean Heart Journal, 2016
- 2016 European Guidelines on cardiovascular disease prevention in clinical practiceEuropean Heart Journal, 2016
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsCirculation, 2014
- ω-3 Fatty Acids and Lutein + Zeaxanthin Supplementation for the Prevention of Cardiovascular DiseaseJAMA Internal Medicine, 2014
- Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease EventsJAMA, 2012
- Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular DiseaseArchives of internal medicine (1960), 2012
- Cardiovascular effects of marine omega-3 fatty acidsThe Lancet, 2010
- Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectivesAtherosclerosis, 2008
- Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular DiseaseCirculation, 2002